HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Palmer, E. D. Search for Related Content PubMed Articles by Palmer, E. D.

A Note on the Treatment of Strongyloidiasis with Intravenous Gentian Violet¹

There appears to be no doubt that gentian violet is at the moment the drug of choice for the treatment of human strongyloidiasis. The oral regimen (0.06 gm. gentian violet medicinal in 1 hour enteric coated tablets t.i.d. until 3.3 gm. have been administered (1)) is apparently widely used, supplemented at times by the transduodenal intubation of a solution of the drug. There are, however, at least two disadvantages to enteral therapy in this disease: the length of the therapeutic course necessary before the stools become larva-free—sometimes amounting to several months—and the failure of the drug to be absorbed from the gastrointestinal tract; the enterally administered dye does not reach the stages of the organism which do the greatest harm—the migrating larvae of the initial infection and of the auto- and hyperinfection stages.

During the management of several cases of strongyloidiasis, it became necessary to treat patients in whom there was dangerous active larval migration, as evidenced by pulmonary inflltratioias and renal hemorrhage, with larvae demonstrable in the sputum and urine.

¹ From the Medical Service, 98th General Hospital, U. S. Army, European Command, APO 407.